When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CPRX - Catalyst Pharma inks Firdapse commercialization deal in Canada
Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals (NASDAQ:CPRX) enters into an agreement with Mississauga, Ontario-based KYE Pharmaceuticals under which the latter will commercialize Firdapse (amifampridine phosphate) in Canada for the treatment of adults with an autoimmune disorder called Lambert-Eaton myasthenic syndrome.
More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,